The European Commission has granted orphan drug designation to Chiesi [...]

VIVEbiotech has expanded its in vivo lentiviral vector portfolio to [...]

Vertex Pharmaceuticals has presented new Phase 3 data showing positive [...]

A European consortium has secured a €1m Eurostars grant to [...]

Intellia Therapeutics has reported positive Phase 3 results for lonvoguran [...]

Scribe Therapeutics has achieved a second success milestone in its [...]

MaxCyte has entered a strategic platform licence with US biotech [...]

Chiesi Group has entered into an exclusive global partnership with [...]

Swedish clinical-stage biotech Anocca AB has secured approximately SEK 440 [...]

Broken String Biosciences has reaffirmed its commitment to supporting the [...]